ABIRAGLOB is an intravenous immunoglobulin (IVIG) preparation. It consists of a broad spe
ABIRAGLOB is an intravenous immunoglobulin (IVIG) preparation. It consists of a broad spectrum of immunoglobulins (antibodies) derived from the plasma of healthy donors. This preparation is used to provide passive immunity to individuals with a weakened or compromised immune system.
Uses:
Primary Immunodeficiency Diseases (PID): ABIRAGLOB is used to treat patients with primary immunodeficiency diseases, where the immune system is unable to produce sufficient antibodies, thus increasing susceptibility to infections.
Secondary Immunodeficiency: It is used in patients with secondary immunodeficiency conditions, such as those resulting from HIV, chemotherapy, or other immunosuppressive treatments.
Autoimmune Diseases: ABIRAGLOB can be used to manage certain autoimmune diseases by modulating the immune system's activity, helping to reduce inflammation and tissue damage.
Acute Infections: In some cases, ABIRAGLOB is administered to patients with acute infections to boost their immune response and help combat the infection more effectively.
Neurological Disorders: It is also used in the treatment of certain neurological disorders, such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP), where it helps in reducing nerve inflammation and improving muscle strength.
Related products